inPROBE
inPROBE is a disruptive platform technology which links targeted therapies with targeted diagnostics and has a potential to become a breakthrough in both cancer treatment as well as cancer diagnostics.
22/11/2023
23/10/2023
⭐️Magdalena Staniszewska, PHD, DSC, Professor KUL with a poster presentation at (ESMO - European Society for Medical Oncology) in Madrid (Spain) titled: "Novel in vivo photonics-immunoassay system, , for the rapid detection of HER2 in "
👉Professor Magdalena Staniszewska needs no introduction. She is an outstanding scientist, co-creator of the inPROBE technology. Co-founder and Chief R&D Officer at SDS Optic Inc. She supervises and coordinates work in the field of , and . She is also the Head of the Company's Scientific Advisory Board.
ℹ️The ESMO Congress is a highly influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world.
07/06/2023
at BIO International Convention 💪🇵🇱🇺🇲
First day at BIO International Convention behind us. 💪 It was great to meet again with peers, colleages and global power players in the biotech and pharma industry at the world's most influential biotech meeting.
Great thanks to organizers Polska Agencja Inwestycji i Handlu - PAIH , Central European BioForum ,
We are keeping our fingers crossed for every company in Polish Biotech Stand 🤞
Kliknij tutaj, aby odebrać Sponsorowane Ogłoszenie.
Kategoria
Skontaktuj się z firmę
Strona Internetowa
Adres
Lublin
20-612